Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects

Nutrients. 2020 Feb 5;12(2):412. doi: 10.3390/nu12020412.

Abstract

Obese subjects showed different cardiovascular risk depending by different insulin sensitivity status. We investigated the difference in left ventricular mass and geometry between metabolically healthy (MHO) and unhealthy (MUHO) obese subjects. From a cohort of 876 obese subjects (48.3 ± 14.1 years) without cardio-metabolic disease and stratified according to increasing values of Matsuda index after 75 g oral glucose tolerance test, we defined MHO (n = 292) those in the upper tertile and MUHO (n = 292) those in the lower tertile. All participants underwent echocardiographic measurements. Left ventricular mass was calculated by Devereux equation and normalized by height2,7 and left ventricular hypertrophy (LVH) was defined by values >44 g/m2.7 for females and >48 g/m2.7 for males. Left ventricular geometric pattern was defined as concentric or eccentric if relative wall thickness was higher or lower than 0.42, respectively. MHO developed more commonly a concentric remodeling (19.9 vs. 9.9%; p = 0.001) and had a reduced risk for LVH (OR 0.46; p < 0.0001) than MUHO, in which the eccentric type was more prevalent (40.4 vs. 5.1%; p < 0.0001). We demonstrated that obese subjects-matched for age, gender and BMI-have different left ventricular mass and geometry due to different insulin sensitivity status, suggesting that diverse metabolic phenotypes lead to alternative myocardial adaptation.

Keywords: cardiac remodeling; insulin-resistance; left ventricular hypertrophy; metabolically healthy obesity; obesity.

MeSH terms

  • Adult
  • Blood Glucose / metabolism
  • Echocardiography
  • Female
  • Glucose Intolerance / complications
  • Glucose Intolerance / physiopathology*
  • Heart Ventricles / diagnostic imaging
  • Humans
  • Hypertrophy, Left Ventricular / epidemiology*
  • Hypertrophy, Left Ventricular / etiology
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Male
  • Middle Aged
  • Obesity / complications
  • Obesity / diagnostic imaging
  • Obesity / physiopathology*
  • Obesity, Metabolically Benign / complications
  • Obesity, Metabolically Benign / diagnostic imaging
  • Obesity, Metabolically Benign / physiopathology*
  • Phenotype
  • Prevalence
  • Risk Factors

Substances

  • Blood Glucose
  • Insulin